Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.

J Med Genet · 2016 · PMC4941144 · PMID 26993266

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Although GL-3 clearance of additional cell types, such as podocytes and cardiomyocytes, takes longer than 6 months, 12 47 48 clearance of vascular endothelial cells may be significant in terms of endothelial cell biology and as a marker of overall glycolipid burden.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.